Esilida Sula Karreci

Esilida Sula Karreci practices at Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health.

Esilida Sula Karreci's NPI, 1447603279, was assigned on July 17, 2016. Esilida Sula Karreci holds Massachusetts license 268691.

Esilida Sula Karreci's primary practice is Beth Israel Deaconess Medical Center, at 330 Brookline Avenue, Boston, MA 02215 in Suffolk County. The practice phone is (617) 667-7000.

Esilida Sula Karreci's primary practice is Beth Israel Deaconess Medical Center in Boston, Massachusetts, part of Beth Israel Lahey Health. Esilida Sula Karreci is also affiliated with Beth Israel Deaconess Hospital-Needham. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center (HMFP).

Dmand AI tracks the electronic health record (EHR) system at each site where Esilida Sula Karreci practices, 2 sites in all. Vendor and product names are available with a free account.

Internal medicine is Esilida Sula Karreci's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Esilida Sula Karreci is licensed in Massachusetts.

CMS data shows 172 Medicare services from Esilida Sula Karreci across 4 procedure codes in 2024, for 106 Medicare patients. Medicare paid $13,299 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 106 Medicare patients who saw Esilida Sula Karreci in 2024. The largest group is 75 to 84, with 34 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 3.28, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Esilida Sula Karreci's median patient age at 72, with 52% women.

In 2024, Esilida Sula Karreci wrote 33 Medicare Part D claims. 79% of them were for generic drugs. CMS names the drug for 24 of them, across 2 drugs with 11 or more claims each, at $174 in total drug cost. In 2020, CMS named 12 claims across 1 drug.

Esilida Sula Karreci accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Esilida Sula Karreci as offering telehealth.

CMS Open Payments shows 1 general payment to Esilida Sula Karreci from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Baxter Healthcare paid the most, $100.